Scientific Library

Application Note

New - Continued use immunotherapy cell line expressing recombinant PD-1

February 03, 2017

PD-1/NFAT-Luciferase reporter jurkat cell line used to monitor the T cell response inhibition via PD-1 interacting with PD-L1/PD-L2

PD-1 / NFAT Reporter

Article

Achieve success with RNA-based CRISPR-CAS9 knock-out

January 15, 2019

RNA-based CRISPR-CAS9 gene editing is a vector-free approach that is required for therapeutic perspectives. However, from a practical point of view, what appears as a major challenge to engineer

Article

New cancer treatment may reawaken the immune system

May 16, 2023

Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form